Bruce Jackson
Stock Analyst at Benchmark
(1.16)
# 1,553
Out of 4,650 analysts
109
Total ratings
30.97%
Success rate
-15.8%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOTH Hoth Therapeutics | Reiterates: Speculative Buy | $3 | $0.98 | +207.57% | 3 | Oct 11, 2024 | |
| MLSS Milestone Scientific | Initiates: Speculative Buy | $1.25 | $0.79 | +57.43% | 1 | Oct 10, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $5.32 | +181.95% | 12 | Oct 10, 2024 | |
| GDTC CytoMed Therapeutics | Reiterates: Speculative Buy | $5 | $2.34 | +113.68% | 4 | Oct 10, 2024 | |
| NEO NeoGenomics | Reiterates: Buy | $18 | $13.52 | +33.14% | 6 | Sep 24, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.48 | +522.54% | 7 | Sep 6, 2024 | |
| MOVE Movano | Reiterates: Speculative Buy | $2 | $4.42 | -54.75% | 2 | Sep 4, 2024 | |
| CDIO Cardio Diagnostics Holdings | Reiterates: Speculative Buy | $2 | $0.26 | +671.60% | 5 | Aug 27, 2024 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Speculative Buy | $17 | $1.18 | +1,340.68% | 4 | Aug 26, 2024 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.60 | - | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.88 | +699.09% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $3.49 | +587.68% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $69.78 | -18.31% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $91 → $67 | $69.64 | -3.79% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $25 | $3.09 | +709.06% | 6 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $0.21 | +376.19% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.38 | +1,467.40% | 6 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $3.10 | +61.29% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.25 | +122.22% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.79 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $30.29 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $7 | $2.45 | +185.71% | 4 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.99 | +26,655.85% | 1 | Aug 8, 2022 |
Hoth Therapeutics
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.98
Upside: +207.57%
Milestone Scientific
Oct 10, 2024
Initiates: Speculative Buy
Price Target: $1.25
Current: $0.79
Upside: +57.43%
Humacyte
Oct 10, 2024
Reiterates: Buy
Price Target: $15
Current: $5.32
Upside: +181.95%
CytoMed Therapeutics
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.34
Upside: +113.68%
NeoGenomics
Sep 24, 2024
Reiterates: Buy
Price Target: $18
Current: $13.52
Upside: +33.14%
Unicycive Therapeutics
Sep 6, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.48
Upside: +522.54%
Movano
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $4.42
Upside: -54.75%
Cardio Diagnostics Holdings
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.26
Upside: +671.60%
Reviva Pharmaceuticals Holdings
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $1.18
Upside: +1,340.68%
VolitionRx
Aug 16, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.60
Upside: -
Aug 16, 2024
Reiterates: Buy
Price Target: $7
Current: $0.88
Upside: +699.09%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $3.49
Upside: +587.68%
Aug 13, 2024
Reiterates: Buy
Price Target: $57
Current: $69.78
Upside: -18.31%
Aug 1, 2024
Maintains: Buy
Price Target: $91 → $67
Current: $69.64
Upside: -3.79%
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $25
Current: $3.09
Upside: +709.06%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $0.21
Upside: +376.19%
May 23, 2024
Reiterates: Buy
Price Target: $100
Current: $6.38
Upside: +1,467.40%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $3.10
Upside: +61.29%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.25
Upside: +122.22%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.79
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $30.29
Upside: -
Jun 22, 2023
Reiterates: Speculative Buy
Price Target: $7
Current: $2.45
Upside: +185.71%
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.99
Upside: +26,655.85%